...
首页> 外文期刊>Ultrasound in Medicine and Biology >COMBINATION OF LYMPHATIC AND INTRAVENOUS CONTRAST-ENHANCED ULTRASOUND FOR EVALUATION OF CERVICAL LYMPH NODE METASTASIS FROM PAPILLARY THYROID CARCINOMA: A PRELIMINARY STUDY
【24h】

COMBINATION OF LYMPHATIC AND INTRAVENOUS CONTRAST-ENHANCED ULTRASOUND FOR EVALUATION OF CERVICAL LYMPH NODE METASTASIS FROM PAPILLARY THYROID CARCINOMA: A PRELIMINARY STUDY

机译:淋巴细胞静脉注射对比增强超声中乳头状甲状腺癌宫颈淋巴结转移的组合:初步研究

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this prospective study was to evaluate the value of the combination of lymphatic contrast-enhanced ultrasound (LCEUS) and intravenous contrast-enhanced ultrasound (IVCEUS) for the identification of cervical lymph node metastasis (CLNM) from papillary thyroid carcinoma (PTC). From November 2018 to March 2019, 24 consecutive patients with PTC were evaluated. All patients underwent routine US, LCEUS and IVCEUS. Pathology was used as the gold standard. After injection of a contrast agent into the thyroid parenchyma, lymphatic vessels and lymph nodes (LNs) could be exclusively displayed as hyper-enhancement on LCEUS. Benign LNs displayed a complete bright ring (100%) and homogeneous perfusion (88.9%) on LCEUS, while displaying centrifugal perfusion (66.7%) and homogenous enhancement (88.9%) on IVCEUS. Perfusion defects (94.9%) and interruption of the bright ring (71.8%) were the two characteristic LCEUS signs for diagnosing CLNM. On IVCEUS, CLNM appeared as centripetal perfusion (59.0%) and heterogeneous enhancement (59.0%). After comparison with pathology, perfusion defect was correlated to the metastatic foci in the medulla and interruption of the bright ring to the tumor seeding in the marginal sinus (all p values <0.05). LCEUS had more value (area under the receiver operating characteristic curve [AUC] = 0.850, 95% confidence interval [CI]: 0.682-1.000) in diagnosing CLNM than IVCEUS (AUC = 0.692, 95% CI: 0.494-0.890) and routine US (AUC = 0.581, 95% CI: 0.367-0.796). The combination of LCEUS and IVCEUS has the highest diagnostic value (AUC = 0.863, 95% CI: 0.696-1.000). LCEUS had higher diagnostic value than IVCEUS and US for CLNM from PTC. The combination of LCEUS and IVCEUS has the highest diagnostic value for CLNM. (E-mail: yma301@163.com) (C) 2020 The Author(s). Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology.
机译:本前瞻性研究的目的是评估淋巴管超声造影(LCEUS)和静脉超声造影(IVCEUS)联合应用在鉴别甲状腺乳头状癌(PTC)颈淋巴结转移(CLNM)中的价值。从2018年11月到2019年3月,对24例PTC患者进行了评估。所有患者均接受常规超声、LCEUS和IVCEUS检查。以病理学为金标准。在甲状腺实质内注射造影剂后,淋巴管和淋巴结(LNs)可以在LCEUS上显示为高增强。良性LNs在LCEUS上显示完全亮环(100%)和均匀灌注(88.9%),而在IVCEUS上显示离心灌注(66.7%)和均匀增强(88.9%)。灌注缺损(94.9%)和亮环中断(71.8%)是诊断CLNM的两个特征性LCEUS征象。在IVCEUS上,CLNM表现为向心灌注(59.0%)和不均匀强化(59.0%)。与病理对照后,灌注缺损与髓质转移灶和边缘窦肿瘤种植的亮环中断相关(所有p值均<0.05)。与IVCEUS(AUC=0.692,95%CI:0.494-0.890)和常规US(AUC=0.581,95%CI:0.367-0.796)相比,LCEUS在诊断CLNM方面具有更大的价值(受试者工作特征曲线下面积[AUC]=0.850,95%置信区间[CI]:0.682-1.000)。LCEUS和IVCEUS联合应用的诊断价值最高(AUC=0.863,95%可信区间:0.696-1.000)。LCEUS对PTC引起的CLNM的诊断价值高于IVCEUS和US。LCEUS和IVCEUS联合应用对CLNM的诊断价值最高。(电子邮件:yma301@163.com)(C)提交人。由爱思唯尔公司代表世界医学与生物学超声联合会出版。

著录项

  • 来源
  • 作者单位

    China Japan Friendship Hosp Dept Intervent Ultrasound Med 2 Ying Hua Yuan St Beijing 100029;

    China Japan Friendship Hosp Dept Intervent Ultrasound Med 2 Ying Hua Yuan St Beijing 100029;

    China Japan Friendship Hosp Dept Pathol Beijing Peoples R China;

    Tumor Hosp Mu Dan Jiang City Dept Ultrasound Mudanjiang Peoples R China;

    China Japan Friendship Hosp Dept Pathol Beijing Peoples R China;

    China Japan Friendship Hosp Dept Intervent Ultrasound Med 2 Ying Hua Yuan St Beijing 100029;

    China Japan Friendship Hosp Dept Intervent Ultrasound Med 2 Ying Hua Yuan St Beijing 100029;

    China Japan Friendship Hosp Dept Intervent Ultrasound Med 2 Ying Hua Yuan St Beijing 100029;

    China Japan Friendship Hosp Dept Intervent Ultrasound Med 2 Ying Hua Yuan St Beijing 100029;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 影像诊断学;
  • 关键词

    Contrast; Ultrasound; Papillary thyroid carcinoma; Metastasis; Lymph nodes;

    机译:对比度;超声;乳头状甲状腺癌;转移;淋巴结;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号